Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | 0.00% | +200.00% |
06-06 | Universal Ibogaine Inc. cancelled the transaction announced on April 22, 2024 | CI |
06-06 | Universal Ibogaine Inc. announced that it has received CAD 0.27 million in funding | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Addiction Treatment Clinics and Ibogaine
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - | |
Dugan Selkirk
IRC | Investor Relations Contact | - | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
James Duncan
BRD | Director/Board Member | - | 23-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 233,512,849 | 231,177,720 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Universal Ibogaine, Inc.
815 8th Avenue South West Suite 600
T2P 3P2, Calgary
+855-426-4246
http://www.universalibogaine.comSector
1st Jan change | Capi. | |
---|---|---|
+200.00% | 3.32M | |
+24.66% | 88.38B | |
-21.76% | 77.56B | |
+1.76% | 26.97B | |
+7.94% | 18.45B | |
-13.50% | 16.57B | |
+3.23% | 15.81B | |
+77.51% | 13.65B | |
+76.96% | 13.06B | |
+23.02% | 12.55B |
- Stock Market
- Equities
- IBO Stock
- Company Universal Ibogaine Inc.